Duchenne Muscular Dystrophy (DMD)

Overview and management of DMD.

Reviewed by Dr Kola Tytler MBBS CertHE MBA MRCGP (General Practitioner)
Last reviewed: 21 October 2025
NeurologyPaediatricsGenetics

Clinical Guidelines

NICE guideline [HST22]: Ataluren for treating Duchenne muscular dystrophy with a nonsense mutation in the dystrophin gene
National
NICE guideline [TA1031]: Vamorolone for treating Duchenne muscular dystrophy in children and young people
National
Adult North Star Network (ANSN): Consensus Document for Duchenne Muscular Dystrophy (DMD) – Therapy Guidelines
Local
Brazilian consensus on Duchenne muscular dystrophy
Local
Clinical practice guidelines for the diagnosis and management of Duchenne muscular dystrophy (2024)
Local
Consensus recommendations and considerations for the delivery of gene therapy in Duchenne muscular dystrophy
Local
Development of respiratory care guidelines for Duchenne muscular dystrophy
Local
Duchenne Muscular Dystrophy and Related Dystrophinopathies: Developing Drugs for Treatment Guidance for Industry
Local
Duchenne Muscular Dystrophy Care Considerations: Diagnosis and Management (2018)
Local
EMQN best practice guidelines for genetic testing in dystrophinopathies
Local
Muscular Dystrophy Association and Parent Project Muscular Dystrophy Joint Consensus Guidelines (2025)
Local
Practice guideline update summary: Corticosteroid treatment of Duchenne muscular dystrophy (2016)
Local
Practice guideline update summary: Corticosteroid treatment of Duchenne muscular dystrophy (2016)
Local